Fred Rein, a partner in Goodwin Procter’s IP Litigation Group, is a U.S. registered patent attorney with 25 years of experience in intellectual property law. He has handled patent cases across the life sciences (including biological products, chemical processes, diagnostic kits, enantiomers, new chemical entities, metabolites, methods of treatment, pharmaceutical formulations and polymorphs) and has extensive experience addressing the complex interplay between FDA and patent law. In addition to his litigation practice, Mr. Rein focuses on strategic counseling and patent-related due diligence.